Home

přepínač Výpočet Ať je to těžké odběr krve hcc marker Situace Lenost etický

The pro-oncogenic effect of the lncRNA H19 in the development of chronic  inflammation-mediated hepatocellular carcinoma | Oncogene
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Oncogene

Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... |  Download Scientific Diagram
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram

obbvie
obbvie

A new perspective on the immune escape mechanism in HCC: onco-foetal  reprogramming | British Journal of Cancer
A new perspective on the immune escape mechanism in HCC: onco-foetal reprogramming | British Journal of Cancer

Gal-1 is a CAF marker and is correlated with the poor prognosis of... |  Download Scientific Diagram
Gal-1 is a CAF marker and is correlated with the poor prognosis of... | Download Scientific Diagram

Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of  hepatocellular carcinoma cells via the miR-624/H3F3B axis | SpringerLink
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis | SpringerLink

CCR9 as a prognostic marker and therapeutic target in hepatocellular  carcinoma
CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma

The immune microenvironment and progression of immunotherapy and  combination therapeutic strategies for hepatocellular carcinoma
The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

Advances in immunotherapy for hepatocellular carcinoma | Nature Reviews  Gastroenterology & Hepatology
Advances in immunotherapy for hepatocellular carcinoma | Nature Reviews Gastroenterology & Hepatology

SciELO - Brasil - CircRNA has_circ_0001806 promotes hepatocellular  carcinoma progression via the miR-193a-5p/MMP16 pathway CircRNA  has_circ_0001806 promotes hepatocellular carcinoma progression via the  miR-193a-5p/MMP16 pathway
SciELO - Brasil - CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway

Serum markers for hepatocellular carcinoma - Clark - 2016 - Clinical Liver  Disease - Wiley Online Library
Serum markers for hepatocellular carcinoma - Clark - 2016 - Clinical Liver Disease - Wiley Online Library

Single-cell analysis reveals the intra-tumor heterogeneity and identifies  MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma  | Cell Death Discovery
Single-cell analysis reveals the intra-tumor heterogeneity and identifies MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma | Cell Death Discovery

epiLiver a novel tumor specific, high throughput and cost-effective blood  test for specific detection of liver cancer (HCC) | medRxiv
epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC) | medRxiv

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor  heterogeneity of HBV-associated hepatocellular carcinoma | Nature  Communications
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma | Nature Communications

miR-217 targeting DKK1 promotes cancer stem cell properties via activation  of the Wnt signaling pathway in hepatocellular carcinoma
miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma

Tumor markers for hepatocellular carcinoma (Review)
Tumor markers for hepatocellular carcinoma (Review)

Global immune characterization of HBV/HCV-related hepatocellular carcinoma  identifies macrophage and T-cell subsets associated with disease  progression | Cell Discovery
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression | Cell Discovery

Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9  Accelerator - Gastroenterology
Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator - Gastroenterology

Sensitivity of markers used to prove hepatocellular carcinoma (HCC)... |  Download Scientific Diagram
Sensitivity of markers used to prove hepatocellular carcinoma (HCC)... | Download Scientific Diagram

Identification of Liver Cancer Progenitors Whose Malignant Progression  Depends on Autocrine IL-6 Signaling: Cell
Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling: Cell

Liver Cancer Tumor Markers | GeneTex
Liver Cancer Tumor Markers | GeneTex

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment  Response Assessment
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment

EGFR activation limits the response of liver cancer to lenvatinib | Nature
EGFR activation limits the response of liver cancer to lenvatinib | Nature